Literature DB >> 2794562

Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis.

J L Kadurugamuwa1, B Hengstler, M A Bray, O Zak.   

Abstract

The possible role of complement factor 5a (C5a) and prostaglandin E2 (PGE2) in cerebrospinal fluid (CSF) pleocytosis and protein accumulation was assessed in a rabbit model of meningitis. Intracisternally administered C5a caused a rapid, early influx of leukocytes into CSF that peaked at 1 h after injection; by 6 h, cell counts were slightly higher than those in controls. Administration of PGE2 or saline did not induce detectable CSF leukocytosis. Coadministration of PGE2 with C5a decreased CSF leukocytosis in a dose-related fashion. Protein concentration increased 30 min after administration of C5a, peaked after 1 h, and remained elevated for 6 h. PGE2 caused a dose-related increase in protein content after 2 h, whereas coadministration caused an inversely dose-related inhibition of the C5a-induced protein influx into CSF. These data suggest that PGE2 in the subarachnoid space exerts an inhibitory action on the C5a-mediated response that is probably not related to its direct effects on protein extravasation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794562     DOI: 10.1093/infdis/160.4.715

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis.

Authors:  P F Stahel; K Frei; A Fontana; H P Eugster; B H Ault; S R Barnum
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits.

Authors:  R A Dumont; B D Car; N N Voitenok; U Junker; B Moser; O Zak; T O'Reilly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 3.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes.

Authors:  P M Faustmann; D Krause; R Dux; R Dermietzel
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 5.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

6.  GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.

Authors:  K D Whitney; J O McNamara
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

Review 7.  Bacterial meningitis: mechanisms of disease and therapy.

Authors:  R F Kornelisse; R de Groot; H J Neijens
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

8.  Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis.

Authors:  Bianca Woehrl; Matthijs C Brouwer; Carmen Murr; Sebastiaan G B Heckenberg; Frank Baas; Hans W Pfister; Aeilko H Zwinderman; B Paul Morgan; Scott R Barnum; Arie van der Ende; Uwe Koedel; Diederik van de Beek
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

Review 9.  Targeting the complement system in bacterial meningitis.

Authors:  Diederik L H Koelman; Matthijs C Brouwer; Diederik van de Beek
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.